Regenerative potential of platelet concentrates in chronic oral mucosal lesions

J Oral Biol Craniofac Res. 2024 Mar-Apr;14(2):216-221. doi: 10.1016/j.jobcr.2024.02.007. Epub 2024 Mar 6.

Abstract

Chronic oral mucosal diseases (COMDs) represent a significant challenge for clinicians and patients. They are commonly associated with chronic pain and negative effects on healing and patient's quality of life. Regenerative medicine including the use of biological autologous blood-derived substances (e.g., platelet concentrates [PCs]), has been reported to improve healing and reduce pain in orthopedic and maxillofacial surgeries as well as chronic oral mucosal diseases. In this review, we aim to describe the different types of PCs and their applications in the management of COMDs such as lichen planus, mucositis, pemphigus vulgaris, mucous membrane pemphigoid, and plasma cell mucositis, in terms of healing potential, pain control, and quality of life. Overall, PC applications seem to enhance healing and reduce pain in patients with COMDs. However, due to the small sample size and the lack of standardized clinical trials, further research is required to support these findings.

Keywords: Oral lesions; Oral ulcers; Platelet concentrates; Platelet-rich fibrin; Platelet-rich plasma.